Known weaknesses

We state them before an investor does.

Say the hard part. These are the reasons BioEquify could fail, and what we are doing about each.

a.
The Norwegian data market is small
Norway-only data licences have a NOK 36–71m/yr ceiling. Scale needs measured programmes, Sweden and Finland, and EU certification.
What we do
Start with cooperatives, where the data is useful today; build programmes and Nordic expansion on the same core.
b.
Cooperatives earn from timber
Reduced harvest conflicts with how cooperatives make money.
What we do
Lead with drained peatland forest and afforestation, where the carbon case does not depend on cutting less.
c.
SR16 is noisy per stand
A single stand estimate carries a wide error band.
What we do
Sell portfolios, never single stands, and invest in plot calibration.
d.
Solo, non-forester founder
The founder built the core but is not a forest scientist.
What we do
A forest-science co-founder is milestone one.
e.
Regulation is outside our control
CRCF incorporation into the EEA and any forest-management methodology depend on Brussels and Oslo.
What we do
Phase 1 is a data service that needs no regulator; certification comes later, if and when a method applies.
f.
Exits in this space are modest
Disclosed exits run from $11.8M (2023) to $45M (2023); no MRV valuation multiple is public.
What we do
Build to be useful to the buyers that already acquire MRV and forest data, and partner first.
g.
Public data is not a moat
Anyone can download SR16.
What we do
Calibration, distribution contracts with cooperatives and scheme recognition must become the moat.

Next step

Measure your forest, not a promise about it.

A portfolio pilot on live national data, priced up front. The founder replies personally.